BioNTech SE (BNTX) Other Working Capital Changes (2021 - 2023)

BioNTech SE has disclosed Other Working Capital Changes across 3 years of filings, most recently posting $86.1 million for Q1 2023.

• Other Working Capital Changes for Q1 2023 came in at $86.1 million, down 14.78% year-over-year; the trailing twelve-month figure through Mar 2023 was $86.1 million (down 14.78% YoY), and the FY2022 annual result was $24.9 million, down 75.82% from the prior year.
• Other Working Capital Changes came in at $86.1 million for Q1 2023 at BioNTech SE, up from $24.9 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $103.0 million in Q4 2021 to a low of $24.9 million in Q4 2022.
• The 3-year median for Other Working Capital Changes is $93.5 million (2023), against an average of $78.7 million.
• Across the five-year window, Other Working Capital Changes plunged 75.82% in 2022 and retreated 14.78% in 2023, its largest moves.
• BioNTech SE's Other Working Capital Changes stood at $103.0 million in 2021, then slumped by 75.82% to $24.9 million in 2022, then jumped by 245.79% to $86.1 million in 2023.
• The last three Other Working Capital Changes figures came in at $86.1 million (Q1 2023), $24.9 million (Q4 2022), and $101.0 million (Q1 2022), per Business Quant data.